Company / Operating Income per Share
Cullinan Therapeutics, Inc. Operating Income per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.37
FY2024
5-year range
-$4.60 / $3.16
FY2020-FY2024
Trend
+26.8%
vs FY2023
Sector context
#147 of 201
Health Care
What the data says
At $-3.37, Cullinan Therapeutics, Inc.'s operating income per share ranks #147 of 201 in the Health Care sector. Declined from $3.16 to $-3.37 over the past 2 years.
Based on SEC 10-K filings.
-3.37 in FY2024.
Declined from $3.16 to $-3.37 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#147 of 201 in Health CareTop 73% of 201This company -$3.37 Sector average -$28.57
▼
+88.2% above sector average
Key checks
Key Insights
- In FY2024, operating income per share increased 26.8% year-over-year.
- Ranks #147 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2022.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$3.37 | +26.8% |
| FY2023 | -$4.60 | -245.6% |
| FY2022 | $3.16 | +256.2% |
| FY2021 | -$2.02 | +33.3% |
| FY2020 | -$3.03 | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026